Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Cash from Financing Activities (2017 - 2025)

Purple Biotech has reported Cash from Financing Activities over the past 6 years, most recently at $89000.0 for Q4 2022.

  • Quarterly Cash from Financing Activities fell 81.42% to $89000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2022, down 26.32% year-over-year, with the annual reading at $6.3 million for FY2025, 6.51% down from the prior year.
  • Cash from Financing Activities was $89000.0 for Q4 2022 at Purple Biotech, down from $569000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $5.3 million in Q4 2020 and troughed at -$162000.0 in Q4 2018.
  • The 5-year median for Cash from Financing Activities is $162000.0 (2022), against an average of $699909.1.
  • Year-over-year, Cash from Financing Activities tumbled 105.14% in 2018 and then soared 5653.12% in 2020.
  • A 5-year view of Cash from Financing Activities shows it stood at -$162000.0 in 2018, then soared by 40.74% to -$96000.0 in 2019, then soared by 5653.12% to $5.3 million in 2020, then tumbled by 91.01% to $479000.0 in 2021, then tumbled by 81.42% to $89000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Cash from Financing Activities are $89000.0 (Q4 2022), $569000.0 (Q3 2022), and $294000.0 (Q2 2022).